Daiichi Sankyo Co. Ltd.

Pharmaceuticals
Japan
Executive 1Joji Nakayama, President; Chief Executive Officer | President; Chief Executive Officer
Executive 2Yuki Sato, Executive Vice President; | Vice-Chairman;
Earnings Per Share Growth (%)428.45%
Cost of Goods Sold (US$ Millions)$2,708
Current Liabilities (US$ Millions)$2,493
Total Assets (US$ Millions)$6,582
Long Term Debt (Millions)N/A
Return on Equity32.55%
Revenue (US$ Millions)$7,706
Total Company Assets$16,614
Revenue Growth (%)-17.78%
Net Income (US$ Millions)$2,673
Earnings Per Share (US$)$3.83
Total Equity (US$ Millions)$10,930
Profit Margin (%)34.69%
Debt To Equity Ratio (%)N/A
Inventories (Millions)$1,258